Accuray's (ARAY) CyberKnife Improves Prostate Cancer Treatment

Published on 27 Mar 2024 on Zacks via Yahoo Finance

Accuray's (ARAY) CyberKnife Improves Prostate Cancer Treatment

Accuray Incorporated ARAY recently announced that new data presented at the 2024 Radiosurgery Society (RSS) Meeting in Chicago supports the use of the CyberKnife System in the treatment of high-risk and recurrent prostate cancer.

The studies build on years of published clinical follow-up with many patients with prostate cancer at different stages of the disease and with individuals who had radiation therapy earlier, demonstrating the adaptability and usefulness of the approach for healthcare teams.

Price Performance

Read the rest of the article

NYSE.DVA price evolution

NYSE.CAH price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

News

Accuray's (ARAY) CyberKnife Improves Prostate Cancer Treatment

NYSE.DVA price evolution

NYSE.CAH price evolution

Want to become a better investor?

Is Trending Stock Cardinal Health, Inc. (CAH) a Buy Now?

Why Is Cardinal Health Stock Trading Lower On Monday? - Cardinal Health (NYSE:CAH)

Cardinal Health Falls After Optum Rx Distribution Contract Ended

Cardinal Health says contract with OptumRx will not be renewed after June

With 89% institutional ownership, Cardinal Health, Inc. (NYSE:CAH) is a favorite amongst the big...

IceCure Medical (ICCM) Submits Final Cryoablation Data to FDA

Here's Why You Should Retain Medtronic (MDT) Stock for Now

GE HealthCare (GEHC), RSNA Unite to Aid Breast Cancer Imaging

Revvity's (RVTY) Launch to Boost Pharma-Contract Partner Tie-Up

S&P 500 (SPX) today: Top movers are Caesars Entertainment Corp and Cardinal Health Inc